FDA-filed SPL labeling · retrieved through openFDA

Pantoprazole

Pantoprazole is a proton pump inhibitor (PPI) that reduces stomach acid, used across oral and intravenous formulations to treat erosive esophagitis, GERD, and conditions that cause the stomach to overproduce acid.

Brand names ProtonixProtonix I.V.Protonix Delayed-Release
Drug class ⓘ Proton Pump Inhibitor
Rx Forms 5 Routes Oral · Intravenous
Dr. Brian Staiger, PharmD, BCPS
Reviewed by Last reviewed Jul 10, 2026
🧬 Where this information comes from Click to expand

The clinical label records used on this page are FDA-filed Structured Product Labeling (SPL) retrieved through openFDA. We identified 123 clinical label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. Forms, routes, brands, labelers, strengths, and NDC product-record counts are built separately from matching FDA National Drug Code Directory records. The linked DailyMed document is a representative official source for verification, not the page’s only clinical source. View the linked label on DailyMed →

At a glance
Linked label effectiveAug 11, 2026
Clinical labels in scope ⓘ123
AvailabilityRx
Earliest approval/marketing year ⓘ2000
FDA-listed product records ⓘ480
Boxed warningNone found in compared labels
How we combine label and product data →
✓No current FDA shortage listed · checked Sep 22, 2026 🚨Recall on record · 3
Other forms & routes:
Injection
⭐ Pantoprazole at a glance The quick version — the full detail is in the Patient Information Guide below.
💊
HelloPharmacist Editorial Team Bottom Line
Pantoprazole is a reliable, widely used acid-suppressing medication that works well for healing and managing acid-related conditions — but it's meant to be used at the lowest dose for the shortest time necessary. Long-term use needs monitoring for magnesium levels, bone health, and Vitamin B-12. Always keep your prescriber updated on all other medications you take, as pantoprazole can interact with several important drugs.
How we write & review this content — our editorial policy →

📖 Pantoprazole: Patient Information Guide

A plain-language walkthrough of Pantoprazole — what it treats, how it works, how it’s taken, side effects, warnings and interactions. Tap any section to expand it.

🎯What it's used for▾

Pantoprazole is a proton pump inhibitor (PPI) approved across multiple oral and intravenous formulations for the following conditions:

  • Short-term treatment of erosive esophagitis (EE) associated with GERD — oral tablets and suspension in adults and children 5 years and older (up to 8 weeks); adults who don't heal may get an additional 8-week course
  • Maintenance of healing of erosive esophagitis — oral tablets and suspension in adults with GERD, to keep it healed and reduce heartburn relapse (studied up to 12 months)
  • Pathological hypersecretory conditions including Zollinger-Ellison Syndrome — oral formulations for long-term treatment in adults; IV formulations for adults
  • GERD with a history of erosive esophagitis (IV, short-term) — IV pantoprazole formulations in adults for up to 10 days when oral treatment isn't possible; PROTONIX I.V. is also approved for pediatric patients 3 months and older for up to 7 days
  • Not approved for upper GI bleeding — IV pantoprazole has not been shown to be safe or effective for this use
⚙️How it works▾

Pantoprazole targets the final step of stomach acid production. It permanently binds to and blocks the (H⁺, K⁺)-ATPase enzyme — the "acid pump" — on the acid-secreting cells (parietal cells) of the stomach lining. This shuts down both resting acid output and acid triggered by food, stress, or other stimuli. Because the binding is permanent, the effect lasts well beyond 24 hours even though the drug itself clears the body quickly.

With once-daily dosing, acid suppression builds over the first week of treatment, reaching around 85% inhibition by day 7. After stopping pantoprazole, acid levels return to normal within about a week — there is no rebound overproduction of acid.

💊How it's taken▾

Oral pantoprazole comes as delayed-release tablets and delayed-release granules (for suspension). Tablets are taken once daily and can be taken without regard to meal timing. The granule suspension should be taken about 30 minutes before a meal, as a high-fat meal can notably reduce how much is absorbed. For conditions causing excess acid production, dosing is typically twice daily. IV formulations are given by healthcare providers only — either as a slow injection or a 15-minute infusion — and are switched to oral therapy as soon as the patient can take medicine by mouth.

  • Tablets: swallow whole — do not crush or chew
  • Granules: can be mixed with a small amount of applesauce or apple juice, or given through a nasogastric tube
  • Always follow your prescriber's instructions for how long to take it
🤒Side effects — in detail▾

Most people tolerate pantoprazole well. The most common side effects reported in adults include:

  • Headache
  • Diarrhea
  • Nausea
  • Stomach pain
  • Vomiting
  • Gas (flatulence)
  • Dizziness
  • Joint pain (arthralgia)

In children, the most commonly reported side effects also include upper respiratory infections, fever, and rash. More serious reactions — including severe skin blistering, kidney inflammation, severe allergic reactions, low magnesium, C. difficile gut infection, and bone fractures with long-term use — are less common but require prompt medical attention.

⚠️Warnings & precautions▾
  • Bone fractures: Long-term or high-dose use has been linked to increased risk of hip, wrist, and spine fractures — use the lowest effective dose for the shortest time
  • Low magnesium (hypomagnesemia): Can occur after 3+ months of use and may cause muscle cramps, irregular heartbeat, tremors, or seizures; your doctor may check magnesium levels periodically
  • C. difficile infection: Reducing stomach acid may increase risk of this serious gut infection; see a doctor for diarrhea that doesn't resolve
  • Kidney inflammation (acute tubulointerstitial nephritis): Can happen at any point during treatment; stop pantoprazole and seek evaluation if suspected
  • Severe skin reactions: Rare but serious — including Stevens-Johnson syndrome and toxic epidermal necrolysis; stop the drug immediately at first sign of blistering or widespread rash
  • Lupus: PPI use has been linked to new or worsening cutaneous and systemic lupus; report skin rashes or joint symptoms
  • Vitamin B-12 deficiency: Possible after 3+ years of daily use; watch for fatigue, numbness, or memory changes
  • Stomach cancer masking: Symptom relief does not rule out gastric cancer in adults — follow up with your doctor if symptoms don't fully resolve or return quickly
🔀What it interacts with▾

Pantoprazole can interact with several important medications — always share your full medication list with your pharmacist and prescriber:

  • Rilpivirine (HIV medication) — contraindicated; pantoprazole significantly reduces rilpivirine levels, risking treatment failure and drug resistance
  • Atazanavir / nelfinavir (HIV medications) — pantoprazole reduces their absorption; avoid combination or follow special prescribing guidance
  • Saquinavir (HIV medication) — pantoprazole increases saquinavir exposure, raising toxicity risk; monitor closely
  • Warfarin (blood thinner) — may raise INR (clotting time), increasing bleeding risk; requires monitoring and possible dose adjustment
  • High-dose methotrexate — pantoprazole may raise methotrexate levels in the blood, potentially causing toxicity; a temporary pause in pantoprazole may be needed
  • Drugs that need stomach acid to absorb (iron, ketoconazole, itraconazole, dasatinib, erlotinib, nilotinib) — reduced stomach acid means less of these drugs may be absorbed
  • Mycophenolate mofetil (transplant medication) — pantoprazole may reduce active drug levels; use with caution in transplant patients
  • Urine THC drug screening tests — may produce false positives; a confirmatory lab test is recommended

This is not a complete list of interactions. Always talk with your doctor or pharmacist before starting, stopping, or changing any medication.

📋Before taking it▾
  • Allergy: Do not take pantoprazole if you are allergic to it, any other PPI, or any substituted benzimidazole — reactions can include anaphylaxis (severe allergic shock) and angioedema (severe swelling)
  • Rilpivirine use: Must not be combined — this is a hard contraindication
  • Pregnancy: Animal studies showed bone changes in offspring; available human data have not shown a clear risk, but advise your doctor if you are pregnant or trying to become pregnant
  • Breastfeeding: Pantoprazole passes into breast milk in small amounts; discuss benefits and risks with your doctor
  • Children: Oral tablets and suspension are approved for children 5 and older for EE/GERD; PROTONIX I.V. is approved for infants 3 months and older for short-term IV use
  • Older adults: Drug levels may be slightly higher in people over 65, but this is generally not clinically significant; normal use is considered appropriate
  • Liver disease: Pantoprazole is extensively metabolized by the liver — tell your doctor if you have liver problems
  • Neuroendocrine tumor testing: Stop pantoprazole at least 14 days before a CgA blood test to avoid a false positive result
  • Osteoporosis risk: If you already have low bone density or risk factors for fractures, discuss long-term PPI use with your doctor
🚑If you take too much▾

Experience with very large pantoprazole doses is limited. Reports of accidental overdose generally fall within the drug's known side-effect profile, and pantoprazole cannot be removed by dialysis. If you suspect an overdose, call Poison Control at 1-800-222-1222 immediately for guidance — treatment is supportive and symptom-based.

📡Pharmacodynamics — effects in the body▾

Pantoprazole produces a dose-related reduction in stomach acid output. After the first 40 mg oral dose, acid is reduced by about 51% within 2.5 hours; after one week of once-daily dosing, the average reduction reaches approximately 85%, with acid suppressed by more than 95% in about half of users. Stomach acid levels return to normal within about a week after stopping the medication — there is no rebound overproduction. With long-term use, pantoprazole causes a moderate, gradual rise in a stomach hormone called gastrin, which generally stabilizes and returns to normal within about 3 months after stopping the drug.

🔬Pharmacokinetics — how your body processes it▾

Pantoprazole tablets are enteric-coated so they pass through the stomach before dissolving — absorption begins in the small intestine. Peak blood levels are reached in about 2.5 hours after an oral dose, with an absolute bioavailability of approximately 77%. The drug is about 98% bound to protein in the blood and is broken down almost entirely by the liver (mainly through the CYP2C19 enzyme pathway), with about 71% excreted in urine and 18% in feces. Despite this extensive processing, pantoprazole has a short half-life of approximately one hour — yet its acid-suppressing effect lasts over 24 hours because it permanently binds to the acid pump. The drug does not accumulate with repeated daily dosing.

📦How to store it▾

Store PROTONIX For Delayed-Release Oral Suspension and PROTONIX Delayed-Release Tablets at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F) .

📄 Written from Pantoprazole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Every point is grounded in that labeling — nothing is invented. How we use AI →

152

Supplements & herbs that interact with Pantoprazole

152 supplements and herbal products have documented interactions with Pantoprazole in the licensed clinical database we use. Most are manageable — but your pharmacist should know about everything you take, including vitamins and herbals.

Severity mix
  • Major · 3
  • Moderate · 100
  • Minor · 49
ACTIVATED CHARCOAL Major GRAPEFRUIT Major ST. JOHN'S WORT Major ACACIA RIGIDULA Moderate ADRAFINIL Moderate AFRICAN WILD POTATO Moderate AMERICAN ELDER Moderate ARTICHOKE Moderate +144 more
Every supplement checked against Pantoprazole — ranked by severity The full interaction hub: 3 major · 100 moderate · 49 minor · every one linked to its full report. Check Pantoprazole against your exact supplements

Educational information from a licensed clinical database (Natural Medicines) — see our data sources & update cadence. Not medical advice: an interaction being documented does not mean it will happen to you; do not start or stop medications or supplements without professional guidance.

9

Nutrient depletion considerations

Pantoprazole has been associated with lower levels of 9 nutrients in the clinical literature. This does not mean a deficiency will occur — it means these may be worth discussing with your pharmacist or healthcare provider, especially with long-term use.

Evidence & significance mix
  • Higher significance · 5
  • Moderate · 1
  • Unrated · 3
CALCIUM Insignificant Depletion FOLIC ACID Insignificant Depletion IRON Insignificant Depletion MAGNESIUM Major Depletion ZINC Insignificant Depletion VITAMIN B12 Moderate Depletion BETA-CAROTENE Insufficient Evidence CHROMIUM Insufficient Evidence +1 more
See the full Pantoprazole nutrient depletion report

Educational information from a licensed clinical database (Natural Medicines) — not medical advice. Do not start or stop medications or supplements without professional guidance.

🩺 Pharmacist Counseling Corner

Quick, plain-English answers to the questions patients ask most about Pantoprazole — the kind of thing our pharmacy team would talk through with you at the counter.

What exactly does pantoprazole do, and how quickly will I feel better? ▾
Pantoprazole shuts down the pumps in your stomach that produce acid. Most people notice relief from heartburn and related symptoms within a few days of starting it, but the full healing effect on the esophagus typically takes the complete course — often 4 to 8 weeks for erosive esophagitis. Don't stop early just because you feel better; the tissue needs time to heal fully.
Does it matter when I take pantoprazole — with food or without? ▾
It depends on the form you're taking. If you're on the delayed-release tablet, you can take it with or without food — meals just delay it a bit but don't affect how much gets absorbed overall. If you're using the granule suspension, you should take it about 30 minutes before a meal. A high-fat meal can significantly reduce how much of the suspension your body absorbs, so timing really does matter with that form.
Are there any medications I should avoid while taking pantoprazole? ▾
Yes, a few important ones. If you take an HIV medication containing rilpivirine, you cannot take pantoprazole — it's a hard no-go combination because pantoprazole dramatically reduces rilpivirine levels in your blood. If you take warfarin (a blood thinner), your INR needs to be monitored more closely. Pantoprazole can also reduce how well certain other drugs are absorbed — like antifungals or some cancer medications — so always let your pharmacist and doctor know everything you're taking.
I've been on pantoprazole for a long time. Is that a problem? ▾
Long-term use is sometimes necessary, but it does come with some real considerations. Over time, it can lower your magnesium levels and make it harder to absorb Vitamin B-12, and there's a modestly increased risk of bone fractures and benign stomach polyps with extended use. The goal is always to use the lowest dose that controls your condition for the shortest time needed. If you've been on it for years, it's worth checking in with your doctor about whether you still need the same dose — or if you still need it at all.
I got a rash after starting pantoprazole. Should I be worried? ▾
A mild rash can sometimes occur, but don't brush it off without checking in with your doctor. In rare cases, pantoprazole can trigger serious skin reactions — like widespread blistering or peeling — that need immediate medical attention. It can also occasionally cause a lupus-like condition with a rash and joint pain. If your rash is spreading quickly, blistering, or comes with fever or joint pain, stop taking the medication and get evaluated right away.
Is pantoprazole safe to take during pregnancy or while breastfeeding? ▾
Human studies available so far haven't shown a clear increase in birth defects with pantoprazole use, but animal studies did show some bone effects in offspring at comparable doses. Because of that uncertainty, the guidance is to use it only if your doctor decides the benefit outweighs the risk and to let them know you're pregnant or planning to be. As for breastfeeding, small amounts do pass into breast milk, but no harmful effects on nursing infants have been reported in available data. Your doctor can help you weigh the options based on your specific situation.
Is Pantoprazole available over the counter? ▾
Pantoprazole is dispensed by prescription according to its FDA labeling, so it isn't sold over the counter. Your prescriber and pharmacist will determine if it's appropriate for you.
When was Pantoprazole first available? ▾
Pantoprazole has been available in the United States since at least 2000, based on FDA approval history (Drugs@FDA) and product marketing records.
Who makes Pantoprazole? ▾
Pantoprazole is supplied by 117 manufacturers listed in the FDA NDC Directory, including NuCare Pharmaceuticals,Inc., Bryant Ranch Prepack, Cardinal Health 107, LLC.

💬 Answers drafted from Pantoprazole’s FDA-approved label information, summarized in plain language with AI, and reviewed by our pharmacy team before publication. Grounded in that labeling — nothing is made up. How we use AI →

🧰 Keep exploring

📊Pantoprazole supplement interactions152 checked — ranked by severity 🌿Drug & Supplement CheckerPantoprazole vs. vitamins & herbs 💬Ask a PharmacistFree answer, usually < 24h 🔎NDC & pricing lookupFind Pantoprazole NDCs & costs 🅰️Browse Drugs A–ZLook up any medication

💊 How Pantoprazole comes

Pantoprazole is available in 5 forms. Different forms and brands can have different approved uses, doses, schedules, and directions. Follow the instructions for your exact product, and do not switch forms without guidance from your prescriber or pharmacist.

Delayed-release tablet

By mouth
Brands Protonix
Available strengths 2 strengths
20 mg 40 mg
348 FDA-listed product records ⓘ

Oral powder

By mouth
Brands Protonix
Available strengths 1 strength
40 mg
13 FDA-listed product records ⓘ

Oral suspension

By mouth
Available strengths 1 strength
40 mg
5 FDA-listed product records ⓘ

Tablet

By mouth
Available strengths 2 strengths
20 mg 40 mg
5 FDA-listed product records ⓘ

📊 Pantoprazole across the U.S. market

How Pantoprazole appears in the FDA’s National Drug Code Directory — including its dosage forms, strengths, brand names, manufacturers, and FDA-listed product records. These are directory records, not sales or prescription volume.

5
Dose forms ⓘ
117
Manufacturers
9
Brand names
480
FDA-listed product records ⓘ
2000
First marketed ⓘ

FDA-listed product records by dose form (tablet variants merged) — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

Also listed with the FDA, not a patient dose form: Powder (28) — bulk drug substance sold to compounders/manufacturers and multi-item kits. These aren’t counted in the dose-form total above.

NuCare Pharmaceuticals,Inc.7%
Bryant Ranch Prepack7%
Cardinal Health 107, LLC6%
A-S Medication Solutions6%
Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.5%
Remedyrepack Inc.4%
Other makers66%

Share of FDA-listed product records by manufacturer — FDA National Drug Code Directory. Record counts are not sales or prescription volume.

📈 How widely Pantoprazole is used

A general measure of how commonly Pantoprazole is prescribed, based on Medicaid — one of the largest public drug programs. The figure below is prescriptions filled in Q1–Q4 2025, summed across every form and brand of the drug.

Think of this as a proxy for how widely Pantoprazole is used, drawn from freely available public data. Medicaid is just one program — these numbers don’t include Medicare, other government coverage, or commercial and cash-pay prescriptions, so real-world use is higher than what’s shown here.

5,789,599
Medicaid prescriptions filled (Q1–Q4 2025)
$65.8M gross Medicaid reimbursement (before mandatory rebates — net cost is lower)

How commonly is Pantoprazole prescribed? Of the 1,596 medications we measure, Pantoprazole ranks #32 by Medicaid prescriptions — more than 98% of them.

Where Pantoprazole ranks among the drugs we measure · Q1–Q4 2025 · neighbors ±5
Total prescriptions — #32 of 1,596
#27 Aspirin 6,339,210 Rx #28 Losartan 5,992,816 Rx #29 Metoprolol 5,974,670 Rx #30 Clonidine 5,852,758 Rx #31 Semaglutide 5,813,664 Rx #32 Pantoprazole 5,789,599 Rx #33 Quetiapine 5,743,048 Rx #34 Triamcinolone 5,724,276 Rx #35 Methylphenidate 5,663,940 Rx #36 Semaglutide Injection 5,616,018 Rx #37 Amoxicillin / Clavulan... 5,453,053 Rx

Utilization by Pantoprazole product

Pick a product to see its own Medicaid numbers. Each chip is one clinical product — a specific strength & dosage form as defined by RxNorm — with brand-name and generic versions combined.

The 40 mg delayed release oral tablet is the most-dispensed Pantoprazole product — about 87% of these Medicaid prescriptions.

pantoprazole 40 MG Delayed Release Oral Tablet Most dispensed

5,019,462 Medicaid prescriptions (Q1–Q4 2025) 87% of Pantoprazole prescriptions shown $49.2M gross reimbursement (before rebates) ≈ $9.81 per prescription (gross)

Summed across the 30 of 265 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 314200

pantoprazole 20 MG Delayed Release Oral Tablet

686,680 Medicaid prescriptions (Q1–Q4 2025) 12% of Pantoprazole prescriptions shown $6.8M gross reimbursement (before rebates) ≈ $9.91 per prescription (gross)

Summed across the 16 of 242 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 251872

pantoprazole 40 MG Injection

65,430 Medicaid prescriptions (Q1–Q4 2025) 1% of Pantoprazole prescriptions shown $3.5M gross reimbursement (before rebates) ≈ $54 per prescription (gross)

Summed across the 21 of 71 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 283669

pantoprazole 40 MG Oral Granules

18,027 Medicaid prescriptions (Q1–Q4 2025) <1% of Pantoprazole prescriptions shown $6.2M gross reimbursement (before rebates) ≈ $345 per prescription (gross)

Summed across the 9 of 18 listed NDC products with Medicaid activity — every brand and generic of this exact strength & form. RxNorm 763306

Shares are of the Medicaid prescriptions shown here. Product grouping follows RxNorm (the National Library of Medicine’s drug terminology), so “one product” means one strength & dosage form regardless of manufacturer. Dollar figures are gross Medicaid reimbursement before mandatory rebates — rebates (often large, especially for brand-name drugs) are confidential, so actual net cost to Medicaid is lower than shown.

Source: Medicaid State Drug Utilization Data (CMS), aggregated by generic ingredient — summed across every NDC (all brands, strengths, salt forms and dosage forms) of Pantoprazole, and across all states and both fee-for-service and managed-care claims. A general popularity signal; it excludes Medicare, commercial insurance and cash prescriptions, so it is not total U.S. use. Based on the 76 of 596 listed Pantoprazole NDCs with Medicaid activity.

🔍 Compare Pantoprazole products

A representative set of FDA-listed product records for Pantoprazole — across manufacturers, strengths, and dosage forms, grouped by form with each product’s manufacturer and how the FDA approved it. The same medicine may be made and packaged by different companies, so a single drug can have many directory entries. (It’s also why a refill can look different — a new shape, color, or box — even though it contains the same medication.)

Showing 200 of 480 products — FDA National Drug Code Directory. See every product, package size and price: browse all 480 Pantoprazole NDCs →

RxNorm Concept Web — From Ingredient to Every Form and Strength

This page starts with one ingredient concept (IN). The branches below show its dose-form concepts (SCDF), then the available clinical drug and strength concepts (SCD). Combination products remain separate concepts with their own pages.

Ingredient (IN) Pantoprazole RxCUI 40790 3 dose forms · 7 strengths
  1. Dose form (SCDF) Delayed Release Oral Tablet RxCUI 373222 In current FDA listings
    Clinical drug / strength (SCD) 20 MG RxCUI 251872 40 MG RxCUI 314200
  3. Dose form (SCDF) Oral Granules RxCUI 763305 In current FDA listings
    Clinical drug / strength (SCD) 40 MG RxCUI 763306

Look up RxCUI 40790 in the RxCUI Atlas →

RxNorm is the U.S. National Library of Medicine’s normalized drug vocabulary. Its concept hierarchy can include forms that are not currently marketed; the status on each branch compares that concept with current FDA listings. RxCUIs identify vocabulary concepts, not individual packages or manufacturers.

🏷️ Sold under these brand names

Protonix Protonix I.V. Protonix Delayed-Release

🏭 Manufacturers & labelers

NuCare Pharmaceuticals,Inc. 23 Bryant Ranch Prepack 22 Cardinal Health 107, LLC 19 A-S Medication Solutions 19 Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. 16 Remedyrepack Inc. 15 Aphena Pharma Solutions - Tennessee, LLC 13 Golden State Medical Supply, Inc. 11 Aurobindo Pharma Limited 11 American Health Packaging 10 Camber Pharmaceuticals, Inc. 9 St. Mary's Medical Park Pharmacy 9 Advanced Rx Pharmacy of Tennessee, LLC 9 Preferred Pharmaceuticals Inc. 8 Amneal Pharmaceuticals LLC 8 Cardinal Health 8 Proficient Rx LP 7 QPharma Inc 7 Dr.Reddy's Laboratories Limited 7 Quality Care Products, LLC 6 Torrent Pharmaceuticals Limited 6 Sun Pharmaceutical Industries, Inc. 6 Direct Rx 6 NCS HealthCare of KY, LLC dba Vangard Labs 6

…and 16 more on the FDA NDC directory.

RxNorm drug class

Pantoprazole belongs to the Proton Pump Inhibitor class.

Pharmacologic class Proton Pump Inhibitor
Drug family (ATC) Proton pump inhibitors
How it works Proton Pump Inhibitors

Classified by RxNorm RxClass — the U.S. National Library of Medicine's standardized drug-classification service (Established Pharmacologic Class from the FDA, the ATC drug family from the WHO, and mechanism of action). Reference only, not medical advice.

🔬 Where this comes from

Core label, product, RxNorm, safety, and utilization data on this page come from the sources identified below. AI-written, editorial, and licensed sections are labeled separately.

📄
FDA-filed drug labels (SPL) Uses, dosing, warnings & side effects from SPL records retrieved through openFDA; the linked representative set can be verified on DailyMed. ✓ Linked label effective Aug 11, 2026
🏭
Forms, brands & labelersAggregated from ingredient-matched FDA National Drug Code Directory product records for Pantoprazole.
📈
Real-world reportsThe FDA Adverse Event Reporting System (FAERS), served through openFDA.
🚨
Recalls & shortagesopenFDA drug-enforcement reports and the FDA drug-shortage database.
🧾 Clinical label set — FDA-filed SPL labels retained for Pantoprazole after exact ingredient or ingredient-combination matching and applicable route/form matching
Clinical labels in scope
123
NDC products indexed
480
Distinct labelers/manufacturers represented
117
Linked representative label ⓘ
Preferred Pharmaceuticals Inc.
Linked label effective
Aug 11, 2026
Composite sections available
23
Linked SPL Set ID
5c14e2f3-625d-4089-a404-440b0ecf72e7
Linked SPL Document ID
b7c006b5-a176-4266-a076-e49595cc7266
Open the linked representative label on DailyMed ↗

How we combine label and product data

HelloPharmacist combines public FDA and NLM records; we don’t author the underlying clinical facts. We identified 123 FDA-filed SPL label sets within the page’s selected clinical scope after exact ingredient or ingredient-combination matching and applicable route/form matching. The representative label is the starting point for the displayed reference monograph; the 12 largest stored in-scope SPL records, which may include that representative, are compared section by section, and the longest available version of each section is retained. Forms, routes, brands, labelers, product-listed strengths, and product-record counts are aggregated separately from ingredient-matched FDA NDC Directory records; package records listed above are associated with the linked SPL; and the normalized concept hierarchy comes from NLM RxNorm.

For canonical ingredient pages, bounded product-attributed indication and administration excerpts may be added to the AI evidence, and the generator is instructed to preserve available product, brand, route, and form qualifiers instead of treating one label as universal. Where a section is identified as AI-written, its plain-language text is generated from bounded label evidence. New draft drug pages remain in the admin review queue before first publication. Preferred Pharmaceuticals Inc. is the representative DailyMed label linked for verification and dates; it is not the sole source used for the page.

This is general education, not medical advice — always consult your doctor or pharmacist about your medications and any medical condition. For the exact wording of the linked representative label, view that label on DailyMed; some displayed composite sections may come from other in-scope SPL labels. Learn how we use AI and our data sources & update cadence.